BNIP3 Contributes to Silibinin-Induced DNA Double Strand Breaks in Glioma Cells Via Inhibition of Mtor.

Cong Hua,Xuanzhong Wang,Shipeng Liang,Xi Chen,Chen Li,Guangqiang You,Chongcheng Wang,Tianfei Luo,Zhenchuan Wang,Pengfei Ge

DOI: https://doi.org/10.1016/j.bbrc.2021.11.110

IF: 3.1

2021-01-01

Biochemical and Biophysical Research Communications

Abstract:BNIP3 is found to eliminate cancer cells via causing mitochondrial damage and endoplasmic reticulum stress, but it remains elusive of its role in regulating DNA double strand breaks (DSBs). In this study, we find that silibinin triggers DNA DSBs, ROS accumulation and expressional upregulation of BNIP3 in glioma cells. Mitigation of ROS with antioxidant GSH significantly inhibits silibinin-induced DNA DSBs and glioma cell death. Then, we find knockdown of BNIP3 with SiRNA obviously prevents silibinin-induced DNA DSBs and ROS accumulation. Mechanistically, BNIP3 knockdown not only reverses silibinin-triggered depletion of cysteine and GSH via maintaining xCT level, but also abrogates catalase decrease. Notably, silibinin-induced dephosphorylation of mTOR is also prevented when BNIP3 is knocked down. Given that activated mTOR could promote xCT expression and inhibit autophagic degradation of catalase, our data suggest that BNIP3 contributes to silibinin-induced DNA DSBs via improving intracellular ROS by inhibition of mTOR.